PiepoliMFHoesAWAgewallSet al.2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.
2.
LiaoXNorataGDPolakJFet al.Normative values for carotid intima media thickness and its progression: Are they transferrable outside of their cohort of origin?Eur J Prev Cardiol2016; 23: 1165–1173.
3.
CoffeySLewandowskiAGarattSet al.Protocol and quality assurance for carotid imaging in 100,000 participants of UK Biobank: Development and assessment. Eur J Prev Cardiol2017; 24: 1799–1806.
4.
MiyataniMAlaviniaSMSzetoMet al.Association between abnormal arterial stiffness and cardiovascular risk factors in people with chronic spinal cord injury. Eur J Prev Cardiol2017; 24: 552–558.
5.
FernbergUFernstromMHurtig-WennloA. Arterial stiffness is associated to cardiorespiratory fitness and body mass index in young Swedish adults: The Lifestyle, Biomarkers, and Atherosclerosis study. Eur J Prev Cardiol2017; 24: 1809–1818.
6.
SiasosGAthanasiouDTerzisGet al.Acute effects of different types of aerobic exercise on endothelial function and arterial stiffness. Eur J Prev Cardiol2016; 23: 1565–1572.
7.
VanderschurenMUiterwaalCSPMvan der EntCKet al.Feasibility and characteristics of arterial stiffness measurement in preschool children. Eur J Prev Cardiol2017; 24: 1895–1902.
8.
Schack-NielsenLMølgaardCLarsenDet al.Arterial stiffness in 10-year old children: Current and early determinants. Br J Nutr2005; 94: 1004–1011.
9.
VernonSTCoffeySBhindiRet al.Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors. Eur J Prev Cardiol2017; 24: 1824–1830.
10.
BandaraPWellerS. Cardiovascular disease: Time to identify emerging environmental risk factors. Eur J Prev Cardiol2017; 24: 1819–1823.
11.
MannucciPM. Air pollution levels and cardiovascular health: Low is not enough. Eur J Prev Cardiol2017; 24: 1851–1853.
12.
YankeyBARothenbergRStrasserSet al.Effect of marijuana use on cardiovascular and cerebrovascular mortality: A study using the National Health and Nutrition Examination Survey linked mortality file. Eur J Prev Cardiol2017; 24: 1833–1840.
13.
BruthansJMayerOJrDe BacquerDet al.Educational level and risk profile and risk control in patients with coronary heart disease. Eur J Prev Cardiol2016; 23: 881–890.
14.
AabyAFriisKChristensenBet al.Health literacy is associated with health behaviour and self-reported health: A large population-based study in individuals with cardiovascular disease. Eur J Prev Cardiol2017; 24: 1880–1888.
15.
LeipoldRRaalFIshakJet al.The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis. Eur J Prev Cardiol2017; 24: 1843–1850.
16.
BruckertEGalloA. Is lomitapide a life-saving drug in homozygous familial hypercholesterolemia. Eur J Prev Cardiol2017; 24: 1841–1842.
17.
BaragettiABalzarottiGGrigoreLet al.PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans. Eur J Prev Cardiol2017; 24: 1870–1877.
SiasosGAthanasiouDTerzisGet al.Acute effects of different types of aerobic exercise on endothelial function and arterial stiffness. Eur J Prev Cardiol2016; 23: 1565–1572.
20.
MaessenMFEijsvogelsTMStevensGet al.Benefits of lifelong exercise training on left ventricular function after myocardial infarction. Eur J Prev Cardiol2017; 24: 1856–1866.
